6U6M image
Deposition Date 2019-08-30
Release Date 2021-03-24
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6U6M
Keywords:
Title:
Crystal structure of a vaccine-elicited anti-HIV-1 rhesus macaque antibody DH840.1
Biological Source:
Source Organism:
Macaca mulatta (Taxon ID: 9544)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.68 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DH840.1 Fab heavy chain
Chain IDs:A (auth: H)
Chain Length:226
Number of Molecules:1
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:DH840.1 Fab light chain
Chain IDs:B (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:Macaca mulatta
Primary Citation
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
Plos Pathog. 17 e1009624 e1009624 (2021)
PMID: 34086838 DOI: 10.1371/journal.ppat.1009624

Abstact

A primary goal of HIV-1 vaccine development is the consistent elicitation of protective, neutralizing antibodies. While highly similar neutralizing antibodies (nAbs) have been isolated from multiple HIV-infected individuals, it is unclear whether vaccination can consistently elicit highly similar nAbs in genetically diverse primates. Here, we show in three outbred rhesus macaques that immunization with Env elicits a genotypically and phenotypically conserved nAb response. From these vaccinated macaques, we isolated four antibody lineages that had commonalities in immunoglobulin variable, diversity, and joining gene segment usage. Atomic-level structures of the antigen binding fragments of the two most similar antibodies showed nearly identical paratopes. The Env binding modes of each of the four vaccine-induced nAbs were distinct from previously known monoclonal HIV-1 neutralizing antibodies, but were nearly identical to each other. The similarities of these antibodies show that the immune system in outbred primates can respond to HIV-1 Env vaccination with a similar structural and genotypic solution for recognizing a particular neutralizing epitope. These results support rational vaccine design for HIV-1 that aims to reproducibly elicit, in genetically diverse primates, nAbs with specific paratope structures capable of binding conserved epitopes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures